Stride director awarded 4,097 restricted shares in equity grant
Stride, Inc. director reported receiving a grant of restricted common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Stride, Inc. director reported receiving a grant of restricted common stock. On 12/04/2025, an indirect account, the S&C Fink Living Trust, acquired 4,097 shares of Stride common stock at a stated price of $0, reflecting an equity award rather than an open‑market purchase. After this grant, the trust holds 175,607 shares of Stride common stock indirectly. These restricted shares will vest on the earlier of December 4, 2026, or the next annual meeting of Stride stockholders.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 4,097 | $0.00 | $0.00 |
Footnotes (1)
- F1. These shares are restricted and will vest on the earlier of (a) December 4, 2026, or (b) the next annual meeting of the stockholders of Stride, Inc.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What insider transaction did Stride (LRN) disclose in this Form 4?
What is the relationship of the reporting person to Stride (LRN)?
Is this Form 4 filing for Stride (LRN) a joint or individual filing?
AI-generated analysis. How Rhea-AI works. Not financial advice.